# Norzer Biology Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/norzer-biology-group

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Latest round: Angel (Mar 14, 2017)
- Investors on record: 1

## About

Established in 2013 and based in Beijing, China, Norzer Biology Group is a medical company that focuses on the research and development of natural products and pharmaceutical products.

The company’s main business is the research, development, and production of natural products and pharmaceuticals derived from plant extracts. The company’s self-developed products include Allicin, Glycyrrhizic Acid, and Triptolide, among others.

The company generates revenue by providing contract research and manufacturing services, as well as through the direct sale of its proprietary products to pharmaceutical companies, health supplement manufacturers, and cosmetic industries.

## Funding rounds

- Angel, Mar 14, 2017 — Blue Peninsula Capital

## Investors

- Blue Peninsula Capital (https://capitalatlas.ai/funds/blue-peninsula-capital) — Angel